These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26346910)

  • 1. High expression of survivin and its splice variants survivin ΔEx3 and survivin 2 B in oral cancers.
    Mishra R; Palve V; Kannan S; Pawar S; Teni T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Oct; 120(4):497-507. PubMed ID: 26346910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional expression analysis of survivin splice variants reveals differential expression of survivin-3α in breast cancer.
    Moniri Javadhesari S; Gharechahi J; Hosseinpour Feizi MA; Montazeri V; Halimi M
    Genet Test Mol Biomarkers; 2013 Apr; 17(4):314-20. PubMed ID: 23368531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expressions of survivin and the splice variants survivin-2B and survivin-DeltaEx3 in bladder cancer and their clinical significance].
    He XF; Wen DG; Hou JQ; He J; Cen JN
    Ai Zheng; 2009 Nov; 28(11):1209-13. PubMed ID: 19895744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.
    Atlasi Y; Mowla SJ; Ziaee SA
    Cancer Detect Prev; 2009; 32(4):308-13. PubMed ID: 19186007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a real-time quantitative polymerase chain reaction method for the quantification of 3 survivin transcripts and evaluation in breast cancer tissues.
    Pavlidou A; Kroupis C; Goutas N; Dalamaga M; Dimas K
    Clin Breast Cancer; 2014 Apr; 14(2):122-31. PubMed ID: 24325949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct expression of Survivin splice variants in breast carcinomas.
    Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
    Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of survivin and its splice variants in gastric cancer.
    Cheng Z; Hu L; Fu W; Zhang Q; Liao X
    J Huazhong Univ Sci Technolog Med Sci; 2007 Aug; 27(4):393-8. PubMed ID: 17828494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
    Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
    Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of survivin splice isoforms in medulloblastomas.
    Li XN; Shu Q; Su JM; Adesina AM; Wong KK; Perlaky L; Antalffy BA; Blaney SM; Lau CC
    Neuropathol Appl Neurobiol; 2007 Feb; 33(1):67-76. PubMed ID: 17239009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis gene signature of Survivin and its splice variant expression in breast carcinoma.
    Végran F; Boidot R; Bonnetain F; Cadouot M; Chevrier S; Lizard-Nacol S
    Endocr Relat Cancer; 2011 Dec; 18(6):783-92. PubMed ID: 21878572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin-deltaEx3: a novel biomarker for diagnosis of papillary thyroid carcinoma.
    Vandghanooni S; Eskandani M; Montazeri V; Halimi M; Babaei E; Feizi MA
    J Cancer Res Ther; 2011; 7(3):325-30. PubMed ID: 22044815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties.
    Mahotka C; Wenzel M; Springer E; Gabbert HE; Gerharz CD
    Cancer Res; 1999 Dec; 59(24):6097-102. PubMed ID: 10626797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo expression of survivin and its splice variant survivin-2B: impact on clinical outcome in acute myeloid leukemia.
    Wagner M; Schmelz K; Wuchter C; Ludwig WD; Dörken B; Tamm I
    Int J Cancer; 2006 Sep; 119(6):1291-7. PubMed ID: 16619249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survivin isoforms and clinicopathological characteristics in colorectal adenocarcinomas using real-time qPCR.
    Pavlidou A; Dalamaga M; Kroupis C; Konstantoudakis G; Belimezi M; Athanasas G; Dimas K
    World J Gastroenterol; 2011 Mar; 17(12):1614-21. PubMed ID: 21472129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional expression of survivin and its splice variants in brain tumors in humans.
    Yamada Y; Kuroiwa T; Nakagawa T; Kajimoto Y; Dohi T; Azuma H; Tsuji M; Kami K; Miyatake S
    J Neurosurg; 2003 Oct; 99(4):738-45. PubMed ID: 14567610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Survivin and Its Splice Variants in Pediatric Acute Lymphoblastic Leukemia.
    Eren-Keleş E; Karabulut HG; Çakmaklı HF; Adaklı B; Köse SK; Uğur-Dinçaslan H; Yavuz G; Ertem M; Tükün A
    Genet Test Mol Biomarkers; 2018 Dec; 22(12):680-685. PubMed ID: 30489176
    [No Abstract]   [Full Text] [Related]  

  • 18. Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma.
    De Maria S; Pannone G; Bufo P; Santoro A; Serpico R; Metafora S; Rubini C; Pasquali D; Papagerakis SM; Staibano S; De Rosa G; Farina E; Emanuelli M; Santarelli A; Mariggiò MA; Lo Russo L; Lo Muzio L
    J Cancer Res Clin Oncol; 2009 Jan; 135(1):107-16. PubMed ID: 18642030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy.
    Freier K; Pungs S; Sticht C; Flechtenmacher C; Lichter P; Joos S; Hofele C
    Int J Cancer; 2007 Feb; 120(4):942-6. PubMed ID: 17187360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance and different properties of survivin splicing variants in gastric cancer.
    Meng H; Lu C; Mabuchi H; Tanigawa N
    Cancer Lett; 2004 Dec; 216(2):147-55. PubMed ID: 15533590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.